MXPA06000651A - Uso de derivados de indazol para el tratamiento de dolor neuropatico. - Google Patents

Uso de derivados de indazol para el tratamiento de dolor neuropatico.

Info

Publication number
MXPA06000651A
MXPA06000651A MXPA06000651A MXPA06000651A MXPA06000651A MX PA06000651 A MXPA06000651 A MX PA06000651A MX PA06000651 A MXPA06000651 A MX PA06000651A MX PA06000651 A MXPA06000651 A MX PA06000651A MX PA06000651 A MXPA06000651 A MX PA06000651A
Authority
MX
Mexico
Prior art keywords
treatment
neuropathic pain
indazole derivatives
linear
carbon atoms
Prior art date
Application number
MXPA06000651A
Other languages
English (en)
Inventor
Alessandra Alisi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MXPA06000651A publication Critical patent/MXPA06000651A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Uso de un compuesto de la formula (I), donde X es CH o N, y cuando X es CH, R es H, OH, una cadena de alquilo lineal o ramificada teniendo de 1 a 3 atomos de carbono, una cadena de alcoxi lineal o ramificada teniendo de 1 a 3 atomos de carbono, o un atomo de halogeno, y cuando X es N, R es H, o una sal de adicion acida del mismo con un acido organico o inorganico farmaceuticamente aceptable, para preparar una composicion farmaceutica activa en el tratamiento de dolor neuropatico.
MXPA06000651A 2003-07-18 2004-07-08 Uso de derivados de indazol para el tratamiento de dolor neuropatico. MXPA06000651A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001468A ITMI20031468A1 (it) 2003-07-18 2003-07-18 Farmaco ativo nel dolore neuropatico
PCT/EP2004/007635 WO2005013989A1 (en) 2003-07-18 2004-07-08 Use of indazole derivatives for the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
MXPA06000651A true MXPA06000651A (es) 2006-03-30

Family

ID=34131194

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000651A MXPA06000651A (es) 2003-07-18 2004-07-08 Uso de derivados de indazol para el tratamiento de dolor neuropatico.

Country Status (22)

Country Link
US (1) US7638534B2 (es)
EP (1) EP1646387B1 (es)
JP (1) JP4881729B2 (es)
KR (1) KR101073993B1 (es)
CN (1) CN100427089C (es)
AR (1) AR045994A1 (es)
AT (1) ATE345134T1 (es)
AU (1) AU2004262878B2 (es)
CA (1) CA2526052C (es)
DE (1) DE602004003251T2 (es)
DK (1) DK1646387T3 (es)
EA (1) EA008144B1 (es)
ES (1) ES2275232T3 (es)
GE (1) GEP20084343B (es)
HK (1) HK1087026A1 (es)
IL (1) IL172101A (es)
IT (1) ITMI20031468A1 (es)
MX (1) MXPA06000651A (es)
PL (1) PL1646387T3 (es)
PT (1) PT1646387E (es)
UA (1) UA81051C2 (es)
WO (1) WO2005013989A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
ES2399066T3 (es) 2008-07-29 2013-03-25 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Compuesto con actividad serotoninérgica, procedimiento para su preparación y composición farmacéutica que lo comprende

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510283A (ja) * 1991-08-20 1994-11-17 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5−ht4レセプター拮抗薬
CZ283619B6 (cs) * 1991-09-12 1998-05-13 Smithkline Beecham P.L.C Použití derivátů kyseliny benzoové pro výrobu farmaceutických prostředků, deriváty kyseliny benzoo vé, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
MA22647A1 (fr) * 1991-09-14 1993-04-01 Smithkline Beecham Plc Procede de preparation d'un ester ou d'un amide d'un nouveau produit .
GB9120628D0 (en) 1991-09-27 1991-11-06 Fujisawa Pharmaceutical Co Pyrrolobenzoxazine derivatives and process for preparation thereof
JP2831467B2 (ja) 1992-03-12 1998-12-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht▲下4▼−受容体アンタゴニストとしての縮合インドール誘導体
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
DE10132746A1 (de) * 2001-07-05 2003-02-06 Gruenenthal Gmbh Substituierte 1-Phenethylpiperidinverbindungen
US6624162B2 (en) * 2001-10-22 2003-09-23 Pfizer Inc. Imidazopyridine compounds as 5-HT4 receptor modulators
EP1546156A1 (en) * 2002-08-10 2005-06-29 Astex Technology Limited 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) * 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.

Also Published As

Publication number Publication date
CA2526052C (en) 2011-08-30
JP2009513544A (ja) 2009-04-02
EP1646387A1 (en) 2006-04-19
CN100427089C (zh) 2008-10-22
JP4881729B2 (ja) 2012-02-22
WO2005013989A1 (en) 2005-02-17
EA008144B1 (ru) 2007-04-27
CA2526052A1 (en) 2005-02-17
AU2004262878B2 (en) 2009-12-17
UA81051C2 (en) 2007-11-26
EA200600271A1 (ru) 2006-06-30
PT1646387E (pt) 2007-01-31
DE602004003251D1 (de) 2006-12-28
ES2275232T3 (es) 2007-06-01
AU2004262878A1 (en) 2005-02-17
DK1646387T3 (da) 2007-03-19
KR101073993B1 (ko) 2011-10-17
GEP20084343B (en) 2008-03-25
KR20060033006A (ko) 2006-04-18
HK1087026A1 (en) 2006-10-06
US20060183775A1 (en) 2006-08-17
IL172101A0 (en) 2009-02-11
PL1646387T3 (pl) 2007-03-30
IL172101A (en) 2011-08-31
EP1646387B1 (en) 2006-11-15
AR045994A1 (es) 2005-11-23
CN1809356A (zh) 2006-07-26
DE602004003251T2 (de) 2007-05-10
US7638534B2 (en) 2009-12-29
ATE345134T1 (de) 2006-12-15
ITMI20031468A1 (it) 2005-01-19

Similar Documents

Publication Publication Date Title
CY1111310T1 (el) Ενωσεις για την αγωγη μεταβολικων διαταραχων
HK1059044A1 (en) Treatment of statin side effects
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
HK1083460A1 (en) Compounds for the treatment of metabolic disorders
MXPA05008600A (es) Compuestos para el tratamiento de desordenes metabolicos.
HK1083462A1 (en) Compounds for the treatment of metabolic disorders
HRP20080492T3 (en) Phenyl-carboxamide compounds useful for treating pain
WO2005012269A8 (ja) 新規アゾール化合物
GB0411056D0 (en) Organic compounds
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
ES2187261A1 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
TW200735864A (en) Immediate release pharmaceutical formulation
ES2180449A1 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
MXPA05008706A (es) 4-[(2, 4- dicloro-5 -metoxifenil) amino]-6 -alcoxi -3- quinolincarbonitrilos para tratamiento de lesiones isquemicas.
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
MXPA06000651A (es) Uso de derivados de indazol para el tratamiento de dolor neuropatico.
HK1044951A1 (en) Novel a-500359 derivatives
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
MY122570A (en) Benzamide derivatives and drugs containing the same
RS20050954A (en) Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
MXPA06004299A (es) Derivados de arilespirofuropiridina.
MXPA05008190A (es) Derivado de oligosacarido.
GEP20084307B (en) Use of 2h- [1, 3] - oxazino [3, 2-a] indole derivatives for the treatment of neuropathic pain

Legal Events

Date Code Title Description
FG Grant or registration